Oncogenic Ras Suppresses Cdk1 in a Complex Manner During the Incubation of Activated Xenopus Egg Extracts

Overview

Journal Arch Biochem Biophys

Publisher Elsevier

Specialties Biochemistry
Biophysics

Date 2013 Feb 5

PMID 23376039

Citations 2

Authors

Tun-Lan Huang

Jerry P Pian

Bin-Tao Pan

Affiliations

Soon will be listed here.

Abstract

The activity of Cdk1 is the driving force for entry into M-phase during the cell cycle. Activation of Cdk1 requires synthesis and accumulation of cyclin B, binding of cyclin B to Cdk1, and removal of the inhibitory tyr-15-Cdk1 phosphorylation. It was previously shown that oncogenic Ras suppresses Cdk1 activation during the incubation of activated Xenopus egg extracts. However, how oncogenic Ras suppresses Cdk1 remained unclear. Using the histone H1 kinase assay to follow Cdk1 activity and Western blot analysis to assess levels of both cyclin B2 and phosphorylated-tyr-15-Cdk1, how oncogenic Ras suppresses Cdk1 is studied. The results indicate that oncogenic Ras suppresses Cdk1 via induction of persistent phosphorylation of tyr-15-Cdk1. Interestingly, the results reveal that, compared with cyclin B2 in control activated egg extracts, which increased, peaked and then declined during the incubation, oncogenic Ras induced continuous accumulation of cyclin B2. The results also indicate that oncogenic Ras induces continuous accumulation of cyclin B2 primarily through stabilization of cyclin B2, which is mediated by constitutive activation of the Raf-Mek-Erk-p90(rsk) pathway. Taken together, these results indicate that oncogenic Ras suppresses Cdk1 in a complex manner: It induces continuous accumulation of cyclin B2, but also causes persistent inhibitory phosphorylation of tyr-15-Cdk1.

Citing Articles

NCAPG-mediated CDK1 promotes malignant progression of non-small cell lung cancer via ERK signaling activation.

Wu Y, Yang M, Chen M, Tian L, Zhu Y, Chen L Am J Cancer Res. 2024; 14(11):5338-5350.

PMID: 39659935 PMC: 11626278. DOI: 10.62347/DNAQ7105.

CDK1 promotes the proliferation of melanocytes in Rex rabbits.

Dai Y, Hu S, Bai S, Li J, Yang N, Zhai P Genes Genomics. 2022; 44(10):1191-1199.

PMID: 35951158 DOI: 10.1007/s13258-022-01283-4.

References

Serrano M, Lin A, McCurrach M, Beach D, Lowe S . Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell. 1997; 88(5):593-602. DOI: 10.1016/s0092-8674(00)81902-9. View

Kumagai A, Dunphy W . The cdc25 protein controls tyrosine dephosphorylation of the cdc2 protein in a cell-free system. Cell. 1991; 64(5):903-14. DOI: 10.1016/0092-8674(91)90315-p. View

Roberts P, Der C . Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene. 2007; 26(22):3291-310. DOI: 10.1038/sj.onc.1210422. View

Pan B, Chen C, Lin S . Oncogenic Ras blocks cell cycle progression and inhibits p34cdc2 kinase in activated Xenopus egg extracts. J Biol Chem. 1994; 269(8):5968-75. View

Nilsson I, Hoffmann I . Cell cycle regulation by the Cdc25 phosphatase family. Prog Cell Cycle Res. 2000; 4:107-14. DOI: 10.1007/978-1-4615-4253-7_10. View

Romeo Y, Zhang X, Roux P . Regulation and function of the RSK family of protein kinases. Biochem J. 2011; 441(2):553-69. DOI: 10.1042/BJ20110289. View

Kraft C, Herzog F, Gieffers C, Mechtler K, Hagting A, Pines J . Mitotic regulation of the human anaphase-promoting complex by phosphorylation. EMBO J. 2003; 22(24):6598-609. PMC: 291822. DOI: 10.1093/emboj/cdg627. View

Gautier J, Solomon M, Booher R, Bazan J, Kirschner M . cdc25 is a specific tyrosine phosphatase that directly activates p34cdc2. Cell. 1991; 67(1):197-211. DOI: 10.1016/0092-8674(91)90583-k. View

Lloyd A . Ras versus cyclin-dependent kinase inhibitors. Curr Opin Genet Dev. 1998; 8(1):43-8. DOI: 10.1016/s0959-437x(98)80060-9. View

10.

Murray A, Kirschner M . Cyclin synthesis drives the early embryonic cell cycle. Nature. 1989; 339(6222):275-80. DOI: 10.1038/339275a0. View

11.

Mueller P, Coleman T, Kumagai A, Dunphy W . Myt1: a membrane-associated inhibitory kinase that phosphorylates Cdc2 on both threonine-14 and tyrosine-15. Science. 1995; 270(5233):86-90. DOI: 10.1126/science.270.5233.86. View

12.

Parker L, Piwnica-Worms H . Inactivation of the p34cdc2-cyclin B complex by the human WEE1 tyrosine kinase. Science. 1992; 257(5078):1955-7. DOI: 10.1126/science.1384126. View

13.

Lahav-Baratz S, Sudakin V, Ruderman J, Hershko A . Reversible phosphorylation controls the activity of cyclosome-associated cyclin-ubiquitin ligase. Proc Natl Acad Sci U S A. 1995; 92(20):9303-7. PMC: 40973. DOI: 10.1073/pnas.92.20.9303. View

14.

Downward J . Targeting RAS signalling pathways in cancer therapy. Nat Rev Cancer. 2003; 3(1):11-22. DOI: 10.1038/nrc969. View

15.

Minshull J, J Blow J, Hunt T . Translation of cyclin mRNA is necessary for extracts of activated xenopus eggs to enter mitosis. Cell. 1989; 56(6):947-56. DOI: 10.1016/0092-8674(89)90628-4. View

16.

King R, Peters J, Tugendreich S, Rolfe M, Hieter P, Kirschner M . A 20S complex containing CDC27 and CDC16 catalyzes the mitosis-specific conjugation of ubiquitin to cyclin B. Cell. 1995; 81(2):279-88. DOI: 10.1016/0092-8674(95)90338-0. View

17.

Bitangcol J, Chau A, Stadnick E, Lohka M, Dicken B, Shibuya E . Activation of the p42 mitogen-activated protein kinase pathway inhibits Cdc2 activation and entry into M-phase in cycling Xenopus egg extracts. Mol Biol Cell. 1998; 9(2):451-67. PMC: 25274. DOI: 10.1091/mbc.9.2.451. View

18.

Daar I, Nebreda A, Yew N, Sass P, Paules R, Santos E . The ras oncoprotein and M-phase activity. Science. 1991; 253(5015):74-6. DOI: 10.1126/science.1829549. View

19.

Erikson E, Maller J . In vivo phosphorylation and activation of ribosomal protein S6 kinases during Xenopus oocyte maturation. J Biol Chem. 1989; 264(23):13711-7. View

20.

Nurse P . Universal control mechanism regulating onset of M-phase. Nature. 1990; 344(6266):503-8. DOI: 10.1038/344503a0. View